Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
ASTRO
Oct 19, 2023, 18:01 |
Blog
James R. Downing: The advancement of science and medicine requires creative thinking and collaboration
James R. Downing, President and Chief Executive Officer at St. Jude Children’s Research Hospital, shared…
Oct 19, 2023, 17:49 |
Opinion
Ben K. D. Pearce: Some rules that help me maintain my peace in this busy career
Ben K. D. Pearce, Postdoctoral Fellow in the Hörst lab at Johns Hopkins University, shared on…
Oct 19, 2023, 17:45 |
Stories
Laura Vater: I decided to treat every person in the hospital as if it were their hardest day
Laura Vater, Gastrointestinal Oncologist at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center,…
Oct 14, 2023, 16:21 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 8
Once again, it's Saturday, and we continue OncoDaily’s series, '100 Influential Women in Oncology: Key…
Oct 12, 2023, 19:25 |
Blog
Arndt Vogel: I am very excited to be part of the new ESMO Journal 'ESMO Real World Data and Digital Oncology' as an associate editor.
Arndt Vogel, shared a post by Oncology Advance on X/Twitter, adding: "I am very excited…
Oct 12, 2023, 01:07 |
Opinion
Katrina Pedersen: P.S. Calling a trial “First-In-Man” will earn autorejection.
Katrina Pedersen, Gastrointestinal Oncologist at Siteman Cancer Center, shared on X/Twitter: "Dear MedTwitter, I have…
Oct 9, 2023, 18:51 |
Opinion
Urvi Shah: If you are a patient with myeloma or any plasma cell disorder please consider filling out this survey.
Urvi Shah, Attending Physician in Myeloma Service at Memorial Sloan Kettering Cancer Centre, shared on X/Twitter:…
Oct 9, 2023, 00:35 |
Drugs
Arndt Vogel: Off the press: Tislelizumab vs Sorafenib as 1st line Treatment for HCC JAMA Oncology.
Arndt Vogel, made the following post on Twitter: "Off the press: Tislelizumab vs Sorafenib as 1st…
Oct 7, 2023, 17:24 |
Blog
Sara De Dosso: A great educational opportunity for young oncologists, with a special interest in GI tumors!
Sara De Dosso, Deputy Head of Medical Oncology and Head of Gastrointestinal Cancer Unit at…
Oct 7, 2023, 17:20 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 7
We continue OncoDaily’s '100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
101
102
103
104
105
All:
1092
Posts:
1021 - 1030
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube